Submitted by Anonymous (not verified) on 8 May 2026 - 9:08
Human medicines European public assessment report (EPAR): Nintedanib Viatris, nintedanib, Date of authorisation: 22/08/2025, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Nintedanib Viatris, nintedanib, Date of authorisation: 22/08/2025, Revision: 1, Status: Authorised